Navigation Links
ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Date:6/3/2008

SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) announced today that it presented objective response rate and available safety data from the Company's Phase 2 clinical study of ANX-510, or CoFactor(R), for the treatment of advanced breast cancer at the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting, which takes place May 30 - June 3, 2008 in Chicago, IL. CoFactor plus 5-FU (5-Fluorouracil) was determined to be a safe, well-tolerated and active treatment regimen in advanced breast cancer patients who are Herceptin receptor (Her2/neu) negative and who have failed prior taxane and anthracycline therapies. Data available from 31 patients indicated a 23% objective response rate with CoFactor plus 5-FU based on investigators' assessments. Objective response rate was based on the number of complete responses and partial responses observed in this study.

The poster presentation, entitled "5,10 methylenetetrahydrofolic acid with 5-fluorouracil as treatment for advanced breast cancer in patients who failed prior treatment with anthracyclines and taxanes: A phase 2 study," was presented by Dr. Joachim P.H. Schupp, Vice President of Medical Affairs on June 2, 2008.

Historically, capecitabine (Xeloda(R)), a widely-used treatment for advanced breast cancer, has demonstrated response rates between 14% and 26% when studied as monotherapy in patients with advanced breast cancer who failed prior treatment with anthracyclines and taxanes. In this well-defined study population, two recently published, Phase 3 clinical trials, where capecitabine was the approved therapy, demonstrated response rates of 14% for capecitabine alone compared with 35% for capecitabine in combination with ixabepil
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
9. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
10. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... --  Millar, Inc. , a leader in catheter-based and ... of Craig Thummel , President/CEO and member of ... to the Company. The Company also announced its leadership ... Executive Management team as his successors. The Board of ... of Sales and Marketing, as President, and also a ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015  Ardelyx, ... focused on cardio-renal, gastrointestinal and metabolic diseases, today announced ... on July 14, 2015, from 8:00 a.m.- 1:00 pm ... The Ardelyx senior management team will ... its lead compound, tenapanor, which has completed Phase 2b ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... SAN DIEGO, Oct. 7 CareFusion Corporation (NYSE: CFN ) ... 2010 on Tuesday, Nov. 10 following the close of trading on ... webcast and conference call on Nov. 10 at 2:00 pm Pacific ... first quarter, ended on Sep. 30, 2009. To access the call ...
... October 7 DBMS Consulting announced that it,has successfully ... Oracle E-Business Suite (EBS) for SIRO Clinpharm, one of ... fully,automated capabilities in management of clinical trial process, clinical,trial ... After this implementation, SIRO gains complete operational ...
Cached Medicine Technology:CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 3
(Date:6/30/2015)... WA (PRWEB) , ... June 30, 2015 , ... ... and Good Neighbor Pharmacy’s premier event and tradeshow, taking place July 29 to ... and purchasing decision makers. , ThoughtSpot is a four-day event for ...
(Date:6/30/2015)... ... June 30, 2015 , ... ADVOCATE, ... they have been awarded the exclusive billing agreements with Jackson Radiology Associates in ... services encompassing their proprietary suite of billing process software functionality called Experience Based ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... buying eyeglasses online , finally its here, http://www.express-glasses.com is ... shipping rates, for many location, ask about shipping with DHL Express when calling ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Dr. Sammy Masri ... sports medicine physician. He specializes in the diagnosis and treatment of non-surgical sports and ... the people who participate in recreational athletics and use exercise to stay healthy and ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Red Hot ... in a recent online poll at http://scoutology.com/novaburgerwars and was selected as “Best ... published in August 2015. , Red Hot & Blue President Randy McCann said, “Everyone ...
Breaking Medicine News(10 mins):Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:ADVOCATE Wins Billing Agreements with Jackson Radiology Associates 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3
... Surat city in Gujarat Wednesday lifted its ban on sales ... of bird flu in the region.,According to officials, the ban ... the 10-km radius of Uchchhal taluka, where bird flu was ... south of here, is adjacent to Maharashtra's Nandurbar district that ...
... the University of Reading in England, has said that a ... and breast cancer. She says that he aluminum-based active ingredient ... ,"Lifetime exposure to estrogen is the risk factor which ... the aluminum salts in antiperspirants enter the body and mimic ...
... that even though it is 60 years since atomic bombs ... survivors are still facing the effects of the onslaught.// ... thyroid nodules, sometime benign and at other times cancerous, that ... has also been observed that the younger the person, the ...
... been found to ease most of the side affects ... susceptible to radiation, according to doctors in Brazil. Their ... the International Journal of Radiation ... Society for Therapeutic Radiology and Oncology.,The reserachers decided to ...
... being wrongly charged for free services such as making a ... charity Age Concern Scotland//. Legally, such food preparation techniques that ... cost. ,The thirteen councils that have been blamed ... Scottish Executive, in an attempt to resolve the issue. A ...
... issue of self harm. Self-Harm is most often misunderstood, but ... and above all, understanding. According to a recent survey, nearly ... a person who self-harms. ,The "see me" campaign ... fore - that nearly 41% of adults conclude that ...
Cached Medicine News:Health News:Amifostine Renders Cancer More Susceptible To Radiation 2
Six inch wide elastic belt transfers the apron weight off the shoulders. 0.5mm front and 0.25mm back with a generous overlap for double protection. Shoulder pads included. Also available without wide...
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... Versatile, pocket-size peripheral ... either a full-function nerve ... block monitor, depending upon ... is attached. Includes NSL-5 ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
Medicine Products: